I m a newbie and have not studied much into mfcb's business structure. Perhaps its income from Laos is tax exempt and the growth in Stenta and Hexa remains in good trajectory, it should be able to maintain at least RM0.10/share per quarter. No?
As highlighted by LongTermInvestor8 earlier and as per the management discussion & analysis in its latest AR, mfcb may see exponential growth moving forward. The current price of below RM4 is still very much undervalued if most of its ventures turn out alright....
The only catch is it may not declare much dividend as it needs to preserved cash for its expansion plan. However, this is good for long term appreciation, I supposed. No?
2 months ago we did an interview with MFCB management which was hosted live. It dragged on for over 2 hours as Mr Yeow was so passionate in sharing about the business, their plans, prospects, challenges, and how they're overcoming it. Unfortunately, i3 does not allow me to share my notes, so for whoever is interested maybe can PM me.
MFCB is one of the most transparent and well managed companies in the whole of bursa malaysia. Ignoring share price movement (which has been static since 2021 mostly, with some volume coming in only lately), business is running on all cylinders.
Excluding the RM122.0 million share of profit in joint venture, I think the result is still good.
However, I have some concerns on the total borrowings (excluding lease liabilities) amounted to RM777.9 million, a RM120.0 million increase from RM657.9 million at the beginning of the year. Even though, the increase was primarily due to additional borrowings to part finance the acquisition of Stenta.
As interest rates will beginning to normalise from 2022 2nd half to 2023 by approximately 1%, hopefully management will take steps to further reduce the borrowings by funding acquisitions via private placements or warrants
@newbie8080 Question was raised during their Quarterly Result Briefing for 4Q2021, management mentioned that the total borrowing is only 1.5years worth of their expected earnings. which is around RM 500mil annually.
To me the lack of ability to pass through raising cost/hedge against devaluation of currency is more concerning as management mentioned in the briefing that they only have 1% fixed rate annual increment for their Don Sa Hong Hydro Powerplant tariff.
They are paid in USD, so it is a good hedge against RM. and dont expect much growth from Don Sahong Dam, it is how they use the profit from DS to grow their other subsidaries.
Plantation Plastic Packaging Oleo Chem
Will be their next growth provided they can manage them well and be profitable
Uplanet, Their hydro is pretty much max, why are you surprised? That is why the PE is low. But how they use their existing cash flow to expand is another question.
Fresh from turning around its newly acquired oleochemicals business, Mega First Corp Bhd (MFCB) has further expanded its exposure in the booming semiconductor space, following its acquisition of a 28.83% stake in Integrated Smart Technology Sdn Bhd (IST) for RM5.56 million. IST, which is involved in automated test machines for the semiconductor sector, is expected to generate around RM10 million per year or around RM2.9 million for MFCB’s equity portion.
Most boring stock.Share price flat for almost 2 years now.Dividend meagre despite so much cash balance after all the new investment spending.No wonder seeing a lot of selling from institutional holders. who canot afford portfolio to show no gain. All the hype for nothing
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
jonathan_k
159 posts
Posted by jonathan_k > 2022-04-20 14:39 | Report Abuse
Today is the day